Target Price | €48.04 |
Price | €43.05 |
Potential | 11.60% |
Number of Estimates | 18 |
18 Analysts have issued a price target Qiagen 2025 . The average Qiagen target price is €48.04. This is 11.60% higher than the current stock price. The highest price target is €54.90 27.54% , the lowest is €42.83 0.50% . | |
A rating was issued by 22 analysts: 14 Analysts recommend Qiagen to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2025 of 11.60% . Most analysts recommend the Qiagen stock at Purchase. |
19 Analysts have issued a sales forecast Qiagen 2024 . The average Qiagen sales estimate is €1.9b . This is 2.41% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €1.9b 4.33% , the lowest is €1.8b 0.41% .
This results in the following potential growth metrics:
2023 | €1.8b | 10.79% |
---|---|---|
2024 | €1.9b | 2.20% |
2025 | €2.0b | 5.32% |
2026 | €2.1b | 6.52% |
2027 | €2.2b | 6.76% |
2028 | €2.4b | 8.37% |
18 Analysts have issued an Qiagen EBITDA forecast 2024. The average Qiagen EBITDA estimate is €643m . This is 2.33% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €770m 22.48% , the lowest is €285m 54.70% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €602m | 19.40% |
---|---|---|
2024 | €643m | 6.88% |
2025 | €712m | 10.65% |
2026 | €779m | 9.52% |
2027 | €828m | 6.27% |
2028 | €893m | 7.75% |
2023 | 33.10% | 9.65% |
---|---|---|
2024 | 34.62% | 4.58% |
2025 | 36.37% | 5.05% |
2026 | 37.40% | 2.83% |
2027 | 37.23% | 0.45% |
2028 | 37.02% | 0.56% |
7 Qiagen Analysts have issued a net profit forecast 2024. The average Qiagen net profit estimate is €91.9m . This is 14.89% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €107m 33.60% , the lowest is €77.8m 2.79% .
This results in the following potential growth metrics and future Net Margins:
2023 | €313m | 21.67% |
---|---|---|
2024 | €91.9m | 70.67% |
2025 | €403m | 338.61% |
2026 | €465m | 15.43% |
2027 | €519m | 11.53% |
2028 | €568m | 9.47% |
2023 | 17.24% | 12.20% |
---|---|---|
2024 | 4.95% | 71.29% |
2025 | 20.61% | 316.36% |
2026 | 22.33% | 8.35% |
2027 | 23.33% | 4.48% |
2028 | 23.56% | 0.99% |
7 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €0.41 . This is 13.89% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €0.48 33.33% , the lowest is €0.35 2.78% .
This results in the following potential growth metrics and future valuations:
2023 | €1.41 | 21.67% |
---|---|---|
2024 | €0.41 | 70.92% |
2025 | €1.81 | 341.46% |
2026 | €2.09 | 15.47% |
2027 | €2.34 | 11.96% |
2028 | €2.56 | 9.40% |
Current | 118.82 | 309.30% |
---|---|---|
2024 | 104.71 | 11.88% |
2025 | 23.87 | 77.20% |
2026 | 20.68 | 13.36% |
2027 | 18.55 | 10.30% |
2028 | 16.94 | 8.68% |
Based on analysts' sales estimates for 2024, the Qiagen stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.38 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 5.17 .
This results in the following potential growth metrics and future valuations:
Current | 5.51 | 7.41% |
---|---|---|
2024 | 5.38 | 2.29% |
2025 | 5.11 | 5.05% |
2026 | 4.80 | 6.12% |
2027 | 4.49 | 6.34% |
2028 | 4.15 | 7.72% |
Current | 5.30 | 8.32% |
---|---|---|
2024 | 5.17 | 2.35% |
2025 | 4.91 | 5.05% |
2026 | 4.61 | 6.12% |
2027 | 4.32 | 6.34% |
2028 | 3.98 | 7.72% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.